Sarcoma / 2013 / Article / Tab 2

Clinical Study

Clinical Activity and Tolerability of a 14-Day Infusional Ifosfamide Schedule in Soft-Tissue Sarcoma

Table 2

Toxicity—number of patients.

ToxicityGrade 1-2 Grade 3-4Total

Fatigue28 (80%)2 (5.7%)30 (85.7%)
Nausea24 (68.6%)5 (14.3%)29 (83%)
Vomiting16 (45.7%)3 (8.6%)19 (54.3%)
Myelosuppression14 (40%)2 (5.7%)16 (45.7%)
Encephalopathy6 (17.1%)6 (17.1%)12 (34.2%)
Constipation10 (28.6%)010 (28.6%)
Diarrhoea4 (11.4%)2 (5.7%)6 (17.1%)
Renal function impairment5 (14.3%)05 (14.3%)
Liver function tests alteration1 (2.8%)01 (2.8%)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.